Omeros Q1 net income $56.1M on $73.1M non-cash gain; YARTEMLEA net sales $9.9M

OMEROS CORP

2026-Q1 EPS reported $0.62 revenue$9,893,000

GAAP net income $56.1M ($0.78/share) vs. net loss $33.5M ($0.58) in Q1 2025; includes $73.1M non-cash gain on embedded derivatives.
Non-GAAP adjusted net loss $17.1M ($0.24/share); total operating expenses fell 22% to $27.3M.
YARTEMLEA launch in Jan 2026: gross sales $11.1M, net sales $9.9M; CMS assigned J-code (eff. July 1) and recommended NTAP (eff. Oct 1).
Cash and short-term investments $135.3M; repaid $17.1M 2026 Notes; only $70.8M 2029 Notes remain (mature June 2029).
Repurchased 0.4M shares at avg $11.70 for $4.2M; MAA for YARTEMLEA under EMA review with decision expected mid-2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.